Many patients suffer from serious adverse effects including respiratory distress and pulmonary edema during and after chemotherapy with paclitaxel or vinorelbine. These effects appear to be due to the activation of neurokinin-1 receptors. The present study investigated the influences of paclitaxel and vinorelbine on the substance P (sP) release from cultured dorsal root ganglion (DRG) cells using a radioimmunoassay. Both 
omitting CaCl 2 . After washing, the cultured DRG cells were pretreated with various inhibitors (amiloride, bisindolylmaleimide I, LaCl 3 and capsazepine, ω-conotoxin GVIA, gabapentin and Gö6976, nicardipine, PKCε translocation inhibitor peptide and ruthenium red) for 15 min at 37 o C. Thereafter, these cells were continuously treated with anti-cancer drugs (paclitaxel, vinorelbine, dacarbazine, fluorouracil and mitomycin C) for the designated period of time (10, 30 and 60 min) at 37 o C. The content of sP collected from Krebs-HEPES buffer was measured by a sensitive radioimmunoassay (Tang et al., 2006) .
Cell fractionation and Western blot analysis
After the treatment of cultured DRG cells with 10 μM of either paclitaxel or vinorelbine for the designated period of time (0, 2, 5 and 10 min) in Krebs-HEPES buffer, the isolation of the membrane and cytosolic protein fractions from those cells was performed according to the manufacturer's instructions of the cell compartment kit (Qiagen, Hilden, Germany). Thereafter, the protein samples were diluted in sodium dodecyl sulfate (SDS) sample buffer, and sonicated. After heating at 95 o C for 5 min, equal amounts of proteins were separated by SDS-polyacrylamide gel electrophoresis and blotted onto polyvinylidene difluoride membranes. The membranes were blocked with blocking buffer containing 5% skim milk overnight at 4 o C and incubated for 2 hr at room temperature with primary mouse IgG antibodies against PKCα (1:1000) and PKCβ (1:250), respectively. After washing, the membranes were further incubated with horseradish peroxidase-linked anti-mouse IgG antibody (1:1000) for 1 hr at room temperature. The immunoreactivity was detected using the ECL plus Western blotting detection system (GE Healthcare, Little Chalfont, Bucks, UK). Finally, the band densities of PKC isoforms in membrane and cytosol fractions were measured using a computerized image analysis program (Scion Image Beta 4.0.3; Scion Corporation, Frederick, MD, USA). The extent of membrane translocation of the PKC isoforms was calculated using the ratio of the PKC isoform-specific band density (membrane/cytosol), according to a previously described method (Pan et al., 2008) .
Measurement of intracellular Ca 2+ concentration
All experiments were performed in Hanks' balanced salt solution (Sigma Chemical, St Louis, MO, USA). The cultured DRG cells plated on glass coverslips with a silicon rubber wall (FlexiPERM; Heraeus Biotechnology, Hanau, Germany) were loaded with 10 μM of fura-2 acetoxymethyl ester for 60 min at room temperature. The fluorescence intensity was measured with the excitation wavelengths of 340 and 380 nm and an emission wavelength of 510 nm. The video image output was digitized by an Argus 50 color image processor (Hamamatsu Photonics, Shizuoka, Japan) as described elsewhere (Hide et al., 1997) .
Statistical analysis
The data are presented as the mean ± SEM of at least three independent experiments.
The statistical analysis of the data was performed by a one-way analysis of variance (ANOVA) followed by Dunnett's test. A probability value (p) of less than 0.05 was considered to be statistically significant.
Results

Both paclitaxel and vinorelbine induced the sP release from cultured rat DRG cells
As shown in Fig.1A , treatment with 10 µM of either paclitaxel or vinorelbine induced a time-dependent release of sP within 60 min after stimulation. Treatment with either paclitaxel or vinorelbine at a concentration range of 0.1-10 µM for 30 min induced the sP release in a dose-dependent manner (Fig.1B) . In contrast, other kinds of anti-cancer drugs including dacarbazine, fluorouracil and mitomycin C did not affect the release of sP (Fig. 1B) . Therefore, the cultured DRG cells treated with 10 µM of either paclitaxel or vinorelbine for 30 min were used to further investigate the mechanism of sP release from cultured DRG cells.
Involvement of protein kinase C activation on the paclitaxel-and vinorelbine-induced sP release
Previous studies have demonstrated the importance of various intracellular cell signaling factors including protein kinase C (PKC) in the regulation of sP release (Tang et al., 2007 and 2008) . Therefore, the effects of PKC inhibitors on the sP release induced by either paclitaxel or vinorelbine were examined. As shown in The cPKCs are divided into three isoforms: PKCα, β and γ (Liu and Heckman, 1998).
In a separate study, the expression of PKCα and β, but not PKCγ has been confirmed in cultured DRG cells (Unpublished data). Therefore, the effect of both paclitaxel and vinorelbine on the translocation of PKCα and β from cytosol to membrane, which is one of the hallmarks of cPKC activation (Liu and Heckman, 1998), were investigated. , 1997; Oshita et al., 2005; Tang et al, 2006; Tang and Nakata, 2008; Trevisani et al., 2007) . Therefore, the involvement of extracellular Ca 2+ was investigated in both the paclitaxel-and vinorelbine-induced sP release. As shown in Fig. 4 , neither paclitaxel nor vinorelbine affected the sP release in the absence of extracellular Ca
2+
. In addition, preincubation with LaCl 3 (300 μM), which blocks Ca 2+ influx (Robertson et al., 1995) , completely suppressed the sP release induced by either paclitaxel or vinorelbine. Next, the effects of several inhibitors of TRP channels and VGCCs on the paclitaxel-and vinorelbine-induced sP release were examined, because the sensitization of these channels may be modulated by PKC including cPKC (Dolphin, 1995; Fehrenbacher et al., 2003; Venkatachalam and Montell, 2007; Tang et al., 2008) . As shown in Figs 
Increases in the concentration of intracellular Ca
Discussion
This study demonstrated for the first time that both paclitaxel and vinorelbine induced the sP release from cultured rat DRG cells in a time-and dose-dependent manner by the influx of extracellular Ca 2+ through the distinct ion channels activated by different isoforms of cPKCs. In addition, other kinds of anti-cancer drugs (dacarbazine, fluorouracil, and mitomycin C), which do not particularly cause hypersensitive reactions during cancer chemotherapy, did not significantly influence the sP release (Fig. 1B) . Therefore, these data suggest that the sP release seems to be considered as a specific indicator of the hypersensitive reactions triggered by anti-mitotic drugs, paclitaxel and vinorelbine.
Frayer et al. (1999) have indicated that a PKC activator, phorbol 12, 13-dibtyrate, evoked the sP release in spinal cord slices, thus suggesting that the activation of PKC is very important in sP release. The present study demonstrated that the effect of paclitaxel as well as vinorelbine on the sP release was dependent on the activation of PKC (Fig. 2) .
The current study used 1 µM Gö6976 for the inhibition of the activity of cPKC, because 1 µM Gö6976 has no effect on the activity of nPKC and atypical PKC (Martiny-Baron et al., 1993) . Therefore, the concentration of Gö6976 used in this study is appropriate to selectively inhibit the activity of cPKCs. PKCε, a member of the nPKCs, plays a major role in the sP release from cultured DRG cells (Tang and Nakata, 2008; Tang et al., 2008) , however, the pharmacological blockade of PKCε did not inhibit either the paclitaxel-or vinorelbine-induced sP release (Fig. 2) . Taken together, these data suggest that the mechanisms of both the paclitaxel-and vinorelbine-induced sP release might be regulated by the activation of cPKCs rather than nPKCs.
Subbaramaiah et al. (2000) showed the paclitaxel-induced expression of cyclooxygenase-2 (COX-2) protein and mRNA in human mammary epithelial cells to be blocked by calphostin C, an inhibitor of PKC, thus suggesting that the activation of PKC might be activated by paclitaxel. The present study indicated that paclitaxel activated only PKCβ, whereas vinorelbine activated both PKCα and β (Fig. 3) (Fig. 3) . These data suggest that paclitaxel and vinorelbine could activate cPKCs first, and then induce the influx of extracellular Ca
2+
, and therefore the influx of extracellular Ca 2+ appears to be essential for both the paclitaxel-and vinorelbine-induced sP release.
This study found that the involvement of the TRP channel family in the paclitaxel-release, but not the vinorelbine-induced sP release, because ruthenium red, which is commonly used as a non-selective inhibitor of TRP channels (Patapoutian et al., 2003) , has substantial inhibitory effects on the paclitaxel-induced actions (Figs. 5 and 6). Previous studies have demonstrated that the activation of TRPV1 closely contributes to the sP release from cultured DRG cells (Tang et al., 2006 and 2008; Tang and Nakata, 2008) . Therefore, TRPV1 could be one of the candidate TRP channels associated with the paclitaxel-induced actions. However, this hypothesis may be excluded, because capsazepine had no significant inhibitory effect on the paclitaxel-induced release (Fig. 5A ). Other studies have indicated that DRG neurons express the other TRP channels including TRPA1, TRPV3, 4 and TRPM8, thus suggesting that the activation of these TRP channels may be involved in the sP release from DRG neurons (Facer et al., 2007; Grant et al., 2007; Trevisani et al., 2007) . Taken together, these data suggest that the paclitaxel-induced sP release might be evoked by the influx of extracellular Ca 2+ through TRP channels other than TRPV1.
VGCCs are composed by heteromultimeric proteins containing a pore forming α1 subunit and auxiliary β, α2/δ and γ subunits, and divided into six groups (L-, N-P-, Q-, R-, and T-types) based on the properties of the α1 subunit (Dolphin, 1995) . A previous study showed that sP and several types of VGCCs are co-expressed in the DRG cells (Scroggs and Fox, 1992) . In practice, we also found that the pretreatment with gabapentin, a selective and potent inhibitor of VGCCs (Gee et al., 1996; Martin et al., 2002) , caused a significant inhibition of the sP release and the intracellular Ca to determine the isoforms of TRP channels and VGCCs and the distinct molecules in these channels which contribute to the modulation of the paclitaxel-and vinorelbine-induced effects.
In conclusion, both paclitaxel and vinorelbine may cause an extracellular Ca 2+ influx through the TRP channels or VGCCs dependent on the activation of respective cPKC isoforms (PKCβ and/or α), thus leading to an increase in the intracellular Ca 2+ concentration, and thereby evoke the sP release from cultured DRG cells. These observations provide an important key to substantially reduce or even prevent the paclitaxel-and vinorelbine-triggered side effects during and after chemotherapy.
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